Minimally invasive esophagectomy provides equivalent oncologic outcomes to open esophagectomy for locally advanced (stage II or III) esophageal carcinoma

Archives of Surgery

Volumn 146, Issue 6, 2011, Pages 711-714

  Singh, Rajneesh K ^a   Pham, Thai H ^b   Diggs, Brian S ^b   Perkins, Serene ^b   Hunter, John G ^b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; IVOR LEWIS ESOPHAGECTOMY; LENGTH OF STAY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE ESOPHAGECTOMY; MINIMALLY INVASIVE SURGERY; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURGICAL MORTALITY; TREATMENT OUTCOME;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM STAGING; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL RATE; THORACOSCOPY; TREATMENT OUTCOME;

EID: 79959345607     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2011.146     Document Type: Article

References (22)

1. National Cancer Institute. Esophageal Cancer Home Page. http://www.cancer.gov/cancertopics/types/esophageal/. Accessed February 2010.
2. Lewis I. The surgical treatment of carcinoma of the oesophagus; with special reference to a new operation for growths of the middle third. Br J Surg. 1946;34:18-31.
3. Atkins BZ, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg. 2004;78(4):1170-1176. (Pubitemid 39303829)
4. Smithers BM, Gotley DC, Martin I, Thomas JM. Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg. 2007;245(2):232-240. (Pubitemid 46148482)
5. Pham TH, Perry KA, Dolan JP, et al. Comparison of perioperative outcomes after combined thoracoscopic-laparoscopic esophagectomy and open Ivor-Lewis esophagectomy. Am J Surg. 2010;199(5):594-598.
6. American Society of Anesthesiologists. ASA Physical Status Classification System, 2008 . http://www.asahq.org/clinical/physicalstatus.htm. Accessed October 2009.
7. Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg. 2003;238(4):486-495. (Pubitemid 38176386)
8. Perry KA, Enestvedt CK, Diggs BS, Jobe BA, Hunter JG. Perioperative outcomes of laparoscopic transhiatal inversion esophagectomy compare favorably with those of combined thoracoscopic-laparoscopic esophagectomy. Surg Endosc. 2009;23(9):2147-2154.
9. Jobe BA, Reavis KM, Davis JJ, Hunter JG. Laparoscopic inversion esophagectomy: simplifying a daunting operation. Dis Esophagus. 2004;17(1):95-97. (Pubitemid 38807885)
10. Jobe BA, Kim CY, Minjarez RC, O'Rourke R, Chang EY, Hunter JG. Simplifying minimally invasive transhiatal esophagectomy with the inversion approach. Arch Surg. 2006;141(9):857-866.
11. Orringer MB, Marshall B, Iannettoni MD. Eliminating the cervical esophagogastric anastomotic leak with a side-to-side stapled anastomosis. J Thorac Cardiovasc Surg. 2000;119(2):277-288. (Pubitemid 30091801)
12. Zingg U, McQuinn A, DiValentino D, et al. Minimally invasive versus open esophagectomy for patients with esophageal cancer. Ann Thorac Surg. 2009;87(3):911-919.
13. Parameswaran R, Veeramootoo D, Krishnadas R, Cooper M, Berrisford R, Wajed S. Comparative experience of open and minimally invasive esophagogastric resection. World J Surg. 2009;33(9):1868-1875.
14. Lerut T, Moons J, Coosemans W, et al. Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence. Ann Surg. 2009;250(5):798-807.
15. Beg MS, Navaneethan U, Atiq M, Komrokji R, Safa M. Outcome of esophageal carcinoma in the Veteran Affairs population: a comparative analysis from the Veteran Affairs Central Cancer Registry. Am J Clin Oncol. 2009;32(3):286-290.
16. Meredith KL, Weber JM, Turaga KK, et al. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer. Ann Surg Oncol. 2010;17(4):1159-1167.
17. Meguid RA, Hooker CM, Taylor JT, et al. Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: does the pattern of recurrence differ for patients with complete response and those with partial or no response? J Thorac Cardiovasc Surg. 2009;138(6):1309-1317.
18. Trivers KF, De Roos AJ, Gammon MD, et al. Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol. 2005;3(3):225-230. (Pubitemid 40568727)
19. Groth SS, Virnig BA, Whitson BA, et al. Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma. J Thorac Cardiovasc Surg. 2010;139(3):612-620.
20. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer. 2008;112(6):1239-1246. (Pubitemid 351429738)
21. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer. 2002;95(7):1434-1443.
22. Donahue JM, Nichols FC, Li Z, et al. Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg. 2009;87(2):392-399.